SARS‐CoV‐2 infections in patients enrolled on the Children's Oncology Group standard‐risk B‐cell acute lymphoblastic leukemia trial, AALL1731

Abstract Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID‐19) in adults; however, data specific to children with leukemia are limited. High‐quality infectious adverse event data from the ongoing Children's Oncology Group (COG) standard‐risk B acute lymphoblastic leu...

Descripció completa

Dades bibliogràfiques

Autors principals:	Caitlin W. Elgarten, John A. Kairalla, Joel C. Thompson, Tamara P. Miller, Cindy Wang, Susan Conway, Mignon L. Loh, Elizabeth A. Raetz, Sumit Gupta, Rachel E. Rau, Anne Angiolillo, Karen R. Rabin, Sarah Alexander
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-08-01
Col·lecció:	eJHaem
Matèries:	B‐ALL pediatrics SARS‐CoV‐2
Accés en línia:	https://doi.org/10.1002/jha2.697
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!